Publicaciones en las que colabora con MARÍA AZUCENA ESPARIS OGANDO (16)

2020

  1. Inhibition of the mitotic kinase PLK1 overcomes therapeutic resistance to BET inhibitors in triple negative breast cancer

    Cancer Letters, Vol. 491, pp. 50-59

2019

  1. Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2016

  1. Neuregulin expression in solid tumors: Prognostic value and predictive role to anti-HER3 therapies

    Oncotarget, Vol. 7, Núm. 29, pp. 45042-45051

  2. Targeting the EGF/HER ligand-receptor system in cancer

    Current Pharmaceutical Design, Vol. 22, Núm. 39, pp. 5887-5898

2014

  1. Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer

    Oncogene, Vol. 33, Núm. 2, pp. 148-156

2009

  1. Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as potential therapeutic target

    PLoS ONE, Vol. 4, Núm. 5

2008

  1. Neuregulins and cancer

    Clinical Cancer Research, Vol. 14, Núm. 11, pp. 3237-3241

2007

  1. Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer

    Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663

  2. The extracellular linker of pro-neuregulin-α2c is required for efficient sorting and juxtacrine function

    Molecular Biology of the Cell, Vol. 18, Núm. 2, pp. 380-393

2005

  1. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin

    Cancer Research, Vol. 65, Núm. 15, pp. 6801-6810

  2. Multifunctional role of Erk5 in multiple myeloma

    Blood, Vol. 105, Núm. 11, pp. 4492-4499

2002

  1. Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2

    Molecular and Cellular Biology, Vol. 22, Núm. 1, pp. 270-285

  2. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor α-converting enzyme at threonine 735: A potential role in regulated shedding

    Molecular Biology of the Cell, Vol. 13, Núm. 6, pp. 2031-2044

  3. Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases

    Biochemical Journal, Vol. 363, Núm. 2, pp. 211-221

2000

  1. Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme

    Molecular and Cellular Neuroscience, Vol. 16, Núm. 5, pp. 631-648

  2. Stimulation of cleavage of membrane proteins by calmodulin inhibitors

    Biochemical Journal, Vol. 346, Núm. 2, pp. 359-367